| Year |
Citation |
Score |
| 2023 |
Shao H, Teramae D, Wells A. Axl contributes to efficient migration and invasion of melanoma cells. Plos One. 18: e0283749. PMID 36989239 DOI: 10.1371/journal.pone.0283749 |
0.316 |
|
| 2021 |
Swogger J, Conner IP, Happ-Smith C, Kemmerer MC, Julian DR, Wells A, Schuman JS, Yates CC, Davis R. Novel combination therapy reduces subconjunctival fibrosis after glaucoma filtration surgery in the rabbit model. Clinical & Experimental Ophthalmology. PMID 33426793 DOI: 10.1111/ceo.13884 |
0.669 |
|
| 2020 |
Swogger J, Conner IP, Rosano M, Kemmerer M, Happ-Smith C, Wells A, Schuman JS, Yates CC. Injected Versus Sponge-Applied Mitomycin C (MMC) During Modified Trabeculectomy in New Zealand White Rabbit Model. Translational Vision Science & Technology. 9: 23. PMID 33150049 DOI: 10.1167/tvst.9.11.23 |
0.65 |
|
| 2020 |
Klimstra WB, Tilston-Lunel NL, Nambulli S, Boslett J, McMillen CM, Gilliland T, Dunn MD, Sun C, Wheeler SE, Wells A, Hartman AL, McElroy AK, Reed DS, Rennick LJ, Duprex WP. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients. The Journal of General Virology. PMID 32821033 DOI: 10.1099/Jgv.0.001481 |
0.303 |
|
| 2020 |
Sylakowski K, Bradshaw A, Wells A. Mesenchymal stem cell/multipotent stromal cell augmentation of wound healing: lessons from the physiology of matrix and hypoxia support. The American Journal of Pathology. PMID 32294456 DOI: 10.1016/J.Ajpath.2020.03.017 |
0.398 |
|
| 2019 |
Ma B, Khazali A, Shao H, Jiang Y, Wells A. Expression of E-cadherin and specific CXCR3 isoforms impact each other in prostate cancer. Cell Communication and Signaling : Ccs. 17: 164. PMID 31831069 DOI: 10.1186/S12964-019-0489-1 |
0.435 |
|
| 2019 |
Shao H, Wingert B, Weins A, Pollak MR, Camacho C, Wells A. Focal segmental glomerulosclerosis ACTN4 mutants binding to actin: regulation by phosphomimetic mutations. Scientific Reports. 9: 15517. PMID 31664084 DOI: 10.1038/S41598-019-51825-2 |
0.338 |
|
| 2019 |
Ma B, Wells A, Clark AM. The pan-therapeutic resistance of disseminated tumor cells: role of phenotypic plasticity and the metastatic microenvironment. Seminars in Cancer Biology. PMID 31376430 DOI: 10.1016/J.Semcancer.2019.07.021 |
0.304 |
|
| 2019 |
Jiang Y, Wells A, Sylakowski K, Clark AM, Ma B. Adult Stem Cell Functioning in the Tumor Micro-Environment. International Journal of Molecular Sciences. 20. PMID 31130595 DOI: 10.3390/Ijms20102566 |
0.383 |
|
| 2019 |
Gau DM, Chakraborty S, Boone D, Wells A, Roy P. Abstract LB-043: MRTF|Profilin is an important signaling axis for metastatic outgrowth of triple negative breast cancer cells Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-Lb-043 |
0.33 |
|
| 2018 |
Wells A, Clark A, Bradshaw A, Ma B, Edington H. The great escape: How metastases of melanoma, and other carcinomas, avoid elimination. Experimental Biology and Medicine (Maywood, N.J.). 243: 1245-1255. PMID 30764707 DOI: 10.1177/1535370218820287 |
0.302 |
|
| 2018 |
Bradshaw A, Sylakowski K, Wells A. The Pro-reparative Engine: Stem Cells Aid Healing by Dampening Inflammation. Current Pathobiology Reports. 6: 109-115. PMID 30271682 DOI: 10.1007/S40139-018-0167-9 |
0.38 |
|
| 2018 |
Wells A, Wiley HS. A systems perspective of heterocellular signaling. Essays in Biochemistry. PMID 30139877 DOI: 10.1042/Ebc20180015 |
0.368 |
|
| 2018 |
Ishikawa T, Hosaka YZ, Beckwitt C, Wells A, Oltvai ZN, Warita K. Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics. Oncotarget. 9: 29304-29315. PMID 30034619 DOI: 10.18632/Oncotarget.25448 |
0.405 |
|
| 2018 |
Beckwitt CH, Shiraha K, Wells A. Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling. Plos One. 13: e0197422. PMID 29763460 DOI: 10.1371/Journal.Pone.0197422 |
0.391 |
|
| 2018 |
Clark AM, Kumar M, Wheeler S, Young C, Venkataramanan R, Stolz D, Griffith L, Lauffenburger DA, Wells A. A model of dormant-emergent metastatic breast cancer progression enabling exploration of biomarker signatures. Molecular & Cellular Proteomics : McP. PMID 29353230 DOI: 10.1074/Mcp.Ra117.000370 |
0.387 |
|
| 2018 |
Beckwitt C, Clark A, Warita K, Oltvai Z, Wells A. Abstract P1-01-20: Adjuvant statin therapy efficacy is dictated by tumor dormancy and statin lipophilicity in ex vivo and in vivo models of metastatic breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-01-20 |
0.348 |
|
| 2017 |
Shao H, Wang A, Lauffenburger D, Wells A. Tyro3-mediated phosphorylation of ACTN4 at tyrosines is FAK-dependent and decreases susceptibility to cleavage by m-Calpain. The International Journal of Biochemistry & Cell Biology. PMID 29274473 DOI: 10.1016/J.Biocel.2017.12.014 |
0.429 |
|
| 2017 |
Raghu VK, Beckwitt CH, Warita K, Wells A, Benos PV, Oltvai ZN. Biomarker identification for statin sensitivity of cancer cell lines. Biochemical and Biophysical Research Communications. PMID 29146185 DOI: 10.1016/J.Bbrc.2017.11.065 |
0.348 |
|
| 2017 |
Dioufa N, Clark AM, Ma B, Beckwitt CH, Wells A. Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells. Molecular Cancer. 16: 172. PMID 29137633 DOI: 10.1186/S12943-017-0740-6 |
0.315 |
|
| 2017 |
Yates CC, Rodrigues M, Nuschke A, Johnson ZI, Whaley D, Stolz D, Newsome J, Wells A. Multipotent stromal cells/mesenchymal stem cells and fibroblasts combine to minimize skin hypertrophic scarring. Stem Cell Research & Therapy. 8: 193. PMID 28874184 DOI: 10.1186/S13287-017-0644-9 |
0.809 |
|
| 2017 |
Shao H, Lauffenburger D, Wells A. Tyro3 carboxyl terminal region confers stability and contains the autophosphorylation sites. Biochemical and Biophysical Research Communications. PMID 28668391 DOI: 10.1016/J.Bbrc.2017.06.168 |
0.305 |
|
| 2017 |
Clark AM, Wheeler SE, Young CL, Neiman JS, Pillai V, Stockdale L, Stolz D, Lauffenburger DA, Venkataramanan R, Griffith LG, Wells A. Abstract A01: Mechanical properties of matrices strongly influence spontaneous tumor dormancy and responses to chemotherapy in a 3D model of metastasis Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-A01 |
0.394 |
|
| 2016 |
Huen AC, Marathi A, Nam PK, Wells A. CXCL11 Expression by Keratinocytes Occurs Transiently Between Reaching Confluence and Cellular Compaction. Advances in Wound Care. 5: 517-526. PMID 28078185 DOI: 10.1089/Wound.2015.0680 |
0.415 |
|
| 2016 |
Clark AM, Wheeler SE, Young CL, Stockdale L, Shepard Neiman J, Zhao W, Stolz DB, Venkataramanan R, Lauffenburger D, Griffith L, Wells A. A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties. Lab On a Chip. PMID 27910972 DOI: 10.1039/C6Lc01171C |
0.371 |
|
| 2016 |
Nuschke A, Rodrigues M, Wells AW, Sylakowski K, Wells A. Mesenchymal stem cells/multipotent stromal cells (MSCs) are glycolytic and thus glucose is a limiting factor of in vitro models of MSC starvation. Stem Cell Research & Therapy. 7: 179. PMID 27906055 DOI: 10.1186/S13287-016-0436-7 |
0.588 |
|
| 2016 |
González Á, García de Durango C, Alonso V, Bravo B, Rodríguez de Gortázar A, Wells A, Forteza J, Vidal-Vanaclocha F. Distinct Osteomimetic Response of Androgen-Dependent and Independent Human Prostate Cancer Cells to Mechanical Action of Fluid Flow: Prometastatic Implications. The Prostate. PMID 27813116 DOI: 10.1002/Pros.23270 |
0.301 |
|
| 2016 |
Ma B, Wheeler SE, Clark AM, Whaley DL, Yang M, Wells A. Liver Protects Metastatic Prostate Cancer From Induced Death by Activating E-cadherin Signaling. Hepatology (Baltimore, Md.). PMID 27482645 DOI: 10.1002/Hep.28755 |
0.425 |
|
| 2016 |
Yates CC, Nuschke A, Rodrigues M, Whaley D, Dechant JJ, Taylor DP, Wells A. Improved transplanted stem cell survival in a polymer gel supplemented with tenascin-C accelerates healing and reduces scarring of murine skin wounds. Cell Transplantation. PMID 27452449 DOI: 10.3727/096368916X692249 |
0.813 |
|
| 2016 |
Nuschke A, Rodrigues M, Rivera J, Yates C, Whaley D, Stolz D, Griffith L, Wells A. Epidermal Growth Factor Tethered to β-Tricalcium Phosphate Bone Scaffolds via a High-Affinity Binding Peptide Enhances Survival of Human Mesenchymal Stem Cells/Multipotent Stromal Cells in an Immune-Competent Parafascial Implantation Assay in Mice. Stem Cells Translational Medicine. PMID 27400798 DOI: 10.5966/Sctm.2015-0326 |
0.81 |
|
| 2016 |
Yang M, Ma B, Shao H, Clark AM, Wells A. Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells. Bmc Cancer. 16: 419. PMID 27387344 DOI: 10.1186/S12885-016-2411-1 |
0.391 |
|
| 2016 |
Bodnar RJ, Satish L, Yates CC, Wells A. Pericytes: A newly recognized player in wound healing. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. PMID 26969517 DOI: 10.1111/Wrr.12415 |
0.773 |
|
| 2016 |
Wells A. Starvation as an Initiator of Mesenchymal Stem Cell/Multipotent Stromal Cell Differentiation Journal of Stem Cell Research & Therapeutics. 1. DOI: 10.15406/Jsrt.2016.01.00020 |
0.367 |
|
| 2016 |
Clark AM, Wheeler SE, Young CL, Pillai VC, Stolz DB, Lauffenburger DA, Venkataramanan R, Griffith LG, Wells A. Abstract PR11: Elucidating candidate biomarkers of breast cancer progression and dormancy using a 3D model of metastasis Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-Pr11 |
0.39 |
|
| 2016 |
Beckwitt C, Wheeler S, Clark A, Pillai V, Young C, Stolz D, Lauffenburger D, Venkataramanan R, Griffith L, Wells A. Abstract P2-05-19: Breast cancer dormancy, re-emergence, and treatment Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-05-19 |
0.376 |
|
| 2016 |
Tripathi S, Karanam B, Ma B, Wells A, Yates C. Abstract 1680: Targeting subcellular localization of Kaiso to limit dissemination through MAPK signaling Cancer Research. 76: 1680-1680. DOI: 10.1158/1538-7445.Am2016-1680 |
0.639 |
|
| 2015 |
Gordonov S, Hwang MK, Wells A, Gertler FB, Lauffenburger DA, Bathe M. Time series modeling of live-cell shape dynamics for image-based phenotypic profiling. Integrative Biology : Quantitative Biosciences From Nano to Macro. PMID 26658688 DOI: 10.1039/C5Ib00283D |
0.341 |
|
| 2015 |
Wells A, Nuschke A, Yates CC. Skin tissue repair: Matrix microenvironmental influences. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 26278492 DOI: 10.1016/J.Matbio.2015.08.001 |
0.789 |
|
| 2015 |
Bodnar RJ, Wells A. Differential regulation of pericyte function by the CXC receptor 3. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. PMID 26207932 DOI: 10.1111/Wrr.12346 |
0.447 |
|
| 2015 |
Travers T, Shao H, Joughin BA, Lauffenburger DA, Wells A, Camacho CJ. Tandem phosphorylation within an intrinsically disordered region regulates ACTN4 function. Science Signaling. 8: ra51. PMID 26012634 DOI: 10.1126/Scisignal.Aaa1977 |
0.763 |
|
| 2015 |
Ma B, Khazali A, Wells A. CXCR3 in carcinoma progression. Histology and Histopathology. 30: 781-92. PMID 25663474 DOI: 10.14670/Hh-11-594 |
0.415 |
|
| 2015 |
Furukawa M, Wheeler S, Clark AM, Wells A. Lung epithelial cells induce both phenotype alteration and senescence in breast cancer cells. Plos One. 10: e0118060. PMID 25635394 DOI: 10.1371/Journal.Pone.0118060 |
0.32 |
|
| 2015 |
Shao H, Kirkwood JM, Wells A. Tenascin-C Signaling in melanoma. Cell Adhesion & Migration. 9: 125-30. PMID 25482624 DOI: 10.4161/19336918.2014.972781 |
0.382 |
|
| 2015 |
Clark AM, Wheeler SE, Taylor DP, Young CL, Pillai VC, Stolz DB, Venkataramanan R, Lauffenburger DA, Griffith LG, Wells A. Abstract P1-07-01: Modeling breast cancer dormancy and re-emergence Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-07-01 |
0.371 |
|
| 2015 |
Furukawa M, Wells A, Wheeler S, Clark AM. Abstract 1426: Lung epithelial cells induce both phenotype alteration and senescence in breast cancer cells Cancer Research. 75: 1426-1426. DOI: 10.1158/1538-7445.Am2015-1426 |
0.374 |
|
| 2014 |
Warita K, Warita T, Beckwitt CH, Schurdak ME, Vazquez A, Wells A, Oltvai ZN. Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion. Scientific Reports. 4: 7593. PMID 25534349 DOI: 10.1038/Srep07593 |
0.396 |
|
| 2014 |
Nuschke A, Rodrigues M, Stolz DB, Chu CT, Griffith L, Wells A. Human mesenchymal stem cells/multipotent stromal cells consume accumulated autophagosomes early in differentiation. Stem Cell Research & Therapy. 5: 140. PMID 25523618 DOI: 10.1186/Scrt530 |
0.571 |
|
| 2014 |
Shao H, Li S, Watkins SC, Wells A. α-Actinin-4 is required for amoeboid-type invasiveness of melanoma cells. The Journal of Biological Chemistry. 289: 32717-28. PMID 25296750 DOI: 10.1074/Jbc.M114.579185 |
0.425 |
|
| 2014 |
Clark AM, Wheeler SE, Taylor DP, Pillai VC, Young CL, Prantil-Baun R, Nguyen T, Stolz DB, Borenstein JT, Lauffenburger DA, Venkataramanan R, Griffith LG, Wells A. A microphysiological system model of therapy for liver micrometastases. Experimental Biology and Medicine (Maywood, N.J.). 239: 1170-9. PMID 24821820 DOI: 10.1177/1535370214532596 |
0.371 |
|
| 2014 |
Jamison J, Wang JH, Wells A. PKCδ regulates force signaling during VEGF/CXCL4 induced dissociation of endothelial tubes. Plos One. 9: e93968. PMID 24699667 DOI: 10.1371/Journal.Pone.0093968 |
0.747 |
|
| 2014 |
Ma B, Wells A. The mitogen-activated protein (MAP) kinases p38 and extracellular signal-regulated kinase (ERK) are involved in hepatocyte-mediated phenotypic switching in prostate cancer cells. The Journal of Biological Chemistry. 289: 11153-61. PMID 24619413 DOI: 10.1074/Jbc.M113.540237 |
0.44 |
|
| 2014 |
Taylor DP, Clark A, Wheeler S, Wells A. Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition. Breast Cancer Research and Treatment. 144: 551-60. PMID 24610032 DOI: 10.1007/S10549-014-2875-0 |
0.396 |
|
| 2014 |
Grahovac J, Wells A. Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 31-40. PMID 24247562 DOI: 10.1038/Labinvest.2013.132 |
0.722 |
|
| 2014 |
Ding Z, Joy M, Bhargava R, Gunsaulus M, Lakshman N, Miron-Mendoza M, Petroll M, Condeelis J, Wells A, Roy P. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene. 33: 2065-74. PMID 23686314 DOI: 10.1038/Onc.2013.166 |
0.386 |
|
| 2013 |
Wheeler SE, Borenstein JT, Clark AM, Ebrahimkhani MR, Fox IJ, Griffith L, Inman W, Lauffenburger D, Nguyen T, Pillai VC, Prantil-Baun R, Stolz DB, Taylor D, Ulrich T, Venkataramanan R, ... Wells A, et al. All-human microphysical model of metastasis therapy. Stem Cell Research & Therapy. 4: S11. PMID 24565274 DOI: 10.1186/Scrt372 |
0.324 |
|
| 2013 |
Jamison J, Lauffenburger D, Wang JC, Wells A. PKCδ localization at the membrane increases matrix traction force dependent on PLCγ1/EGFR signaling. Plos One. 8: e77434. PMID 24155954 DOI: 10.1371/Journal.Pone.0077434 |
0.743 |
|
| 2013 |
Bodnar RJ, Rodgers ME, Chen WC, Wells A. Pericyte regulation of vascular remodeling through the CXC receptor 3. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 2818-29. PMID 24135023 DOI: 10.1161/Atvbaha.113.302012 |
0.349 |
|
| 2013 |
Hang TC, Tedford NC, Reddy RJ, Rimchala T, Wells A, White FM, Kamm RD, Lauffenburger DA. Vascular endothelial growth factor (VEGF) and platelet (PF-4) factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context. Molecular & Cellular Proteomics : McP. 12: 3704-18. PMID 24023389 DOI: 10.1074/Mcp.M113.030528 |
0.376 |
|
| 2013 |
Wells A, Griffith L, Wells JZ, Taylor DP. The dormancy dilemma: quiescence versus balanced proliferation. Cancer Research. 73: 3811-6. PMID 23794703 DOI: 10.1158/0008-5472.Can-13-0356 |
0.368 |
|
| 2013 |
Wells A, Grahovac J, Wheeler S, Ma B, Lauffenburger D. Targeting tumor cell motility as a strategy against invasion and metastasis. Trends in Pharmacological Sciences. 34: 283-9. PMID 23571046 DOI: 10.1016/J.Tips.2013.03.001 |
0.69 |
|
| 2013 |
Rodrigues M, Yates CC, Nuschke A, Griffith L, Wells A. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Engineering. Part A. 19: 1972-83. PMID 23541003 DOI: 10.1089/Ten.Tea.2012.0568 |
0.821 |
|
| 2013 |
Shao H, Travers T, Camacho CJ, Wells A. The carboxyl tail of alpha-actinin-4 regulates its susceptibility to m-calpain and thus functions in cell migration and spreading. The International Journal of Biochemistry & Cell Biology. 45: 1051-63. PMID 23466492 DOI: 10.1016/J.Biocel.2013.02.015 |
0.754 |
|
| 2013 |
Travers T, Shao H, Wells A, Camacho CJ. Modeling the assembly of the multiple domains of α-actinin-4 and its role in actin cross-linking. Biophysical Journal. 104: 705-15. PMID 23442921 DOI: 10.1016/J.Bpj.2012.12.003 |
0.759 |
|
| 2013 |
Taylor DP, Wells JZ, Savol A, Chennubhotla C, Wells A. Modeling boundary conditions for balanced proliferation in metastatic latency. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1063-70. PMID 23329811 DOI: 10.1158/1078-0432.Ccr-12-3180 |
0.312 |
|
| 2013 |
Grahovac J, Becker D, Wells A. Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C. The Journal of Investigative Dermatology. 133: 210-20. PMID 22951722 DOI: 10.1038/Jid.2012.263 |
0.735 |
|
| 2013 |
Rodrigues M, Blair H, Stockdale L, Griffith L, Wells A. Surface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from FasL-induced apoptosis. Stem Cells (Dayton, Ohio). 31: 104-16. PMID 22948863 DOI: 10.1002/Stem.1215 |
0.611 |
|
| 2013 |
Taylor DP, Wells A. Abstract C93: Liver nonparenchymal cells drive metastatic breast cancer survival but fail to initiate mesenchymal to epithelial reversion Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C93 |
0.356 |
|
| 2013 |
Kumar DSS, Wells A. Abstract 2973: CXCR3 epigenome switches splice variants in prostate cancer. Cancer Research. 73: 2973-2973. DOI: 10.1158/1538-7445.Am2013-2973 |
0.351 |
|
| 2013 |
Ma B, Wells A. Abstract 2820: The mechanism of mesenchymal-to-epithelial transition driven by hepatocytes in prostate cancer. Cancer Research. 73: 2820-2820. DOI: 10.1158/1538-7445.Am2013-2820 |
0.402 |
|
| 2013 |
Wheeler S, Taylor D, Clark A, Borenstein J, Ebrahimkhani, Inman W, Nguyen T, Pillai V, Prantil-Baun R, Ulrich T, Venkataramanan R, Lauffenburger D, Griffith L, Stolz D, Wells A. Abstract P5-04-08: Modeling breast cancer dormancy Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-04-08 |
0.39 |
|
| 2013 |
Travers T, Shao H, Wells A, Camacho CJ. Modeling of Multi-Domain Assemblies in α-Actinin-4 Reveals How External Cues Regulate its Binding to Actin Biophysical Journal. 104: 647a. DOI: 10.1016/J.Bpj.2012.11.3573 |
0.749 |
|
| 2012 |
Huen AC, Wells A. The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing. Advances in Wound Care. 1: 244-248. PMID 24527313 DOI: 10.1089/Wound.2011.0355 |
0.432 |
|
| 2012 |
Yates CC, Hebda P, Wells A. Skin wound healing and scarring: fetal wounds and regenerative restitution. Birth Defects Research. Part C, Embryo Today : Reviews. 96: 325-33. PMID 24203921 DOI: 10.1002/Bdrc.21024 |
0.767 |
|
| 2012 |
Jones J, Wang H, Zhou J, Hardy S, Turner T, Austin D, He Q, Wells A, Grizzle WE, Yates C. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells. The American Journal of Pathology. 181: 1836-46. PMID 22974583 DOI: 10.1016/J.Ajpath.2012.08.008 |
0.613 |
|
| 2012 |
Yates-Binder CC, Rodgers M, Jaynes J, Wells A, Bodnar RJ, Turner T. An IP-10 (CXCL10)-derived peptide inhibits angiogenesis. Plos One. 7: e40812. PMID 22815829 DOI: 10.1371/Journal.Pone.0040812 |
0.383 |
|
| 2012 |
Gunasinghe NP, Wells A, Thompson EW, Hugo HJ. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Reviews. 31: 469-78. PMID 22729277 DOI: 10.1007/S10555-012-9377-5 |
0.342 |
|
| 2012 |
Meyer AS, Hughes-Alford SK, Kay JE, Castillo A, Wells A, Gertler FB, Lauffenburger DA. 2D protrusion but not motility predicts growth factor-induced cancer cell migration in 3D collagen. The Journal of Cell Biology. 197: 721-9. PMID 22665521 DOI: 10.1083/Jcb.201201003 |
0.353 |
|
| 2012 |
Rodrigues M, Turner O, Stolz D, Griffith LG, Wells A. Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligand. Cell Transplantation. 21: 2171-87. PMID 22526333 DOI: 10.3727/096368912X639035 |
0.586 |
|
| 2012 |
Wu Q, Dhir R, Wells A. Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion. Molecular Cancer. 11: 3. PMID 22236567 DOI: 10.1186/1476-4598-11-3 |
0.427 |
|
| 2012 |
Yates CC, Whaley D, Wells A. Transplanted fibroblasts prevents dysfunctional repair in a murine CXCR3-deficient scarring model. Cell Transplantation. 21: 919-31. PMID 22236446 DOI: 10.3727/096368911X623817 |
0.778 |
|
| 2012 |
Chao Y, Wu Q, Shepard C, Wells A. Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance Clinical and Experimental Metastasis. 29: 39-50. PMID 21964676 DOI: 10.1007/S10585-011-9427-3 |
0.621 |
|
| 2012 |
Chao Y, Wu Q, Acquafondata M, Dhir R, Wells A. Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 5: 19-28. PMID 21892699 DOI: 10.1007/S12307-011-0085-4 |
0.612 |
|
| 2012 |
Taylor DP, Wells A. Abstract 5240: Breast cancer in the metastatic niche: A role for stress-induced dormancy Cancer Research. 72: 5240-5240. DOI: 10.1158/1538-7445.Am2012-5240 |
0.37 |
|
| 2012 |
Grahovac J, Wells A. Abstract 485: Epidermal growth factor-like repeats of Tenascin C promote melanoma cell invasion, possibly by enabling mesenchymal to ameboid migration transition Cancer Research. 72: 485-485. DOI: 10.1158/1538-7445.Am2012-485 |
0.74 |
|
| 2012 |
Kumar DSS, Wells A. Abstract 4016: Epigenetic regulation of CXCR3 splicing in prostate cancer cells Cancer Research. 72: 4016-4016. DOI: 10.1158/1538-7445.Am2012-4016 |
0.335 |
|
| 2011 |
Kim HD, Meyer AS, Wagner JP, Alford SK, Wells A, Gertler FB, Lauffenburger DA. Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts. Molecular & Cellular Proteomics : McP. 10: M111.008433. PMID 21832255 DOI: 10.1074/Mcp.M111.008433 |
0.417 |
|
| 2011 |
Wu S, Wells A, Griffith LG, Lauffenburger DA. Controlling multipotent stromal cell migration by integrating "course-graining" materials and "fine-tuning" small molecules via decision tree signal-response modeling. Biomaterials. 32: 7524-31. PMID 21782235 DOI: 10.1016/J.Biomaterials.2011.06.050 |
0.419 |
|
| 2011 |
Meran S, Luo DD, Simpson R, Martin J, Wells A, Steadman R, Phillips AO. Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction. The Journal of Biological Chemistry. 286: 17618-30. PMID 21454519 DOI: 10.1074/Jbc.M111.226563 |
0.314 |
|
| 2011 |
Yates CC, Bodnar R, Wells A. Matrix control of scarring. Cellular and Molecular Life Sciences : Cmls. 68: 1871-81. PMID 21390544 DOI: 10.1007/S00018-011-0663-0 |
0.767 |
|
| 2011 |
Wells A, Chao YL, Grahovac J, Wu Q, Lauffenburger DA. Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Frontiers in Bioscience (Landmark Edition). 16: 815-37. PMID 21196205 DOI: 10.2741/3722 |
0.775 |
|
| 2011 |
Grahovac J, Wells A. Abstract 421: Epidermal growth factor-like repeats of tenascin C alter melanoma cell migration both directly and through alteration of the ECM Cancer Research. 71: 421-421. DOI: 10.1158/1538-7445.Am2011-421 |
0.738 |
|
| 2011 |
Chao Y, Wu Q, Acquafondata M, Dhir R, Wells A. Abstract 3357: Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases Cancer Research. 71: 3357-3357. DOI: 10.1158/1538-7445.Am2011-3357 |
0.607 |
|
| 2010 |
Bae YH, Ding Z, Das T, Wells A, Gertler F, Roy P. Profilin1 regulates PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells. Proceedings of the National Academy of Sciences of the United States of America. 107: 21547-52. PMID 21115820 DOI: 10.1073/Pnas.1002309107 |
0.411 |
|
| 2010 |
Shao H, Wang JH, Pollak MR, Wells A. α-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. Plos One. 5: e13921. PMID 21085685 DOI: 10.1371/Journal.Pone.0013921 |
0.349 |
|
| 2010 |
Rodrigues M, Griffith LG, Wells A. Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Research & Therapy. 1: 32. PMID 20977782 DOI: 10.1186/Scrt32 |
0.595 |
|
| 2010 |
Silver K, Leloup L, Freeman LC, Wells A, Lillich JD. Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease. The International Journal of Biochemistry & Cell Biology. 42: 2030-6. PMID 20854926 DOI: 10.1016/J.Biocel.2010.09.007 |
0.395 |
|
| 2010 |
Krishna P, Regner M, Palko J, Liu F, Abramowitch S, Jiang J, Wells A. The effects of decorin and HGF-primed vocal fold fibroblasts in vitro and ex vivo in a porcine model of vocal fold scarring. The Laryngoscope. 120: 2247-57. PMID 20830759 DOI: 10.1002/Lary.21087 |
0.361 |
|
| 2010 |
Leloup L, Shao H, Bae YH, Deasy B, Stolz D, Roy P, Wells A. m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5-bisphosphate. The Journal of Biological Chemistry. 285: 33549-66. PMID 20729206 DOI: 10.1074/Jbc.M110.123604 |
0.374 |
|
| 2010 |
Chao YL, Shepard CR, Wells A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Molecular Cancer. 9: 179. PMID 20609236 DOI: 10.1186/1476-4598-9-179 |
0.614 |
|
| 2010 |
Hood BL, Grahovac J, Flint MS, Sun M, Charro N, Becker D, Wells A, Conrads TP. Proteomic analysis of laser microdissected melanoma cells from skin organ cultures. Journal of Proteome Research. 9: 3656-63. PMID 20459140 DOI: 10.1021/Pr100164X |
0.698 |
|
| 2010 |
Yates CC, Krishna P, Whaley D, Bodnar R, Turner T, Wells A. Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring. The American Journal of Pathology. 176: 1743-55. PMID 20203286 DOI: 10.2353/Ajpath.2010.090564 |
0.789 |
|
| 2010 |
Tamama K, Kawasaki H, Wells A. Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. Journal of Biomedicine & Biotechnology. 2010: 795385. PMID 20182548 DOI: 10.1155/2010/795385 |
0.35 |
|
| 2010 |
Simpson RM, Wells A, Thomas D, Stephens P, Steadman R, Phillips A. Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling. The American Journal of Pathology. 176: 1215-28. PMID 20093489 DOI: 10.2353/Ajpath.2010.090802 |
0.357 |
|
| 2010 |
Li M, Aliotta JM, Asara JM, Wu Q, Dooner MS, Tucker LD, Wells A, Quesenberry PJ, Ramratnam B. Intercellular transfer of proteins as identified by stable isotope labeling of amino acids in cell culture. The Journal of Biological Chemistry. 285: 6285-97. PMID 20026604 DOI: 10.1074/Jbc.M109.057943 |
0.363 |
|
| 2010 |
Shao H, Wu C, Wells A. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin. The Journal of Biological Chemistry. 285: 2591-600. PMID 19920151 DOI: 10.1074/Jbc.M109.035790 |
0.375 |
|
| 2010 |
Wu Q, Wells A. Abstract 5199: Promotion of prostate cancer cell migration and invasion via CXCR3 signaling Cancer Research. 70: 5199-5199. DOI: 10.1158/1538-7445.Am10-5199 |
0.412 |
|
| 2010 |
Chao Y, Wells A. Abstract 2336: E-cadherin re-expression affects the growth and survival of breast cancer cells in metastatic colonization of the liver Cancer Research. 70: 2336-2336. DOI: 10.1158/1538-7445.Am10-2336 |
0.626 |
|
| 2009 |
Platt MO, Wilder CL, Wells A, Griffith LG, Lauffenburger DA. Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells. Stem Cells (Dayton, Ohio). 27: 2804-14. PMID 19750537 DOI: 10.1002/Stem.215 |
0.428 |
|
| 2009 |
Ding Z, Gau D, Deasy B, Wells A, Roy P. Both actin and polyproline interactions of profilin-1 are required for migration, invasion and capillary morphogenesis of vascular endothelial cells. Experimental Cell Research. 315: 2963-73. PMID 19607826 DOI: 10.1016/J.Yexcr.2009.07.004 |
0.361 |
|
| 2009 |
Platt MO, Roman AJ, Wells A, Lauffenburger DA, Griffith LG. Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells. Journal of Cellular Physiology. 221: 306-17. PMID 19544388 DOI: 10.1002/Jcp.21854 |
0.436 |
|
| 2009 |
Marcantonio NA, Boehm CA, Rozic RJ, Au A, Wells A, Muschler GF, Griffith LG. The influence of tethered epidermal growth factor on connective tissue progenitor colony formation. Biomaterials. 30: 4629-38. PMID 19540579 DOI: 10.1016/J.Biomaterials.2009.05.061 |
0.41 |
|
| 2009 |
Bodnar RJ, Yates CC, Rodgers ME, Du X, Wells A. IP-10 induces dissociation of newly formed blood vessels. Journal of Cell Science. 122: 2064-77. PMID 19470579 DOI: 10.1242/Jcs.048793 |
0.793 |
|
| 2009 |
Yates CC, Whaley D, Hooda S, Hebda PA, Bodnar RJ, Wells A. Delayed reepithelialization and basement membrane regeneration after wounding in mice lacking CXCR3. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 17: 34-41. PMID 19152649 DOI: 10.1111/J.1524-475X.2008.00439.X |
0.788 |
|
| 2009 |
Bae YH, Ding Z, Zou L, Wells A, Gertler F, Roy P. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins. Journal of Cellular Physiology. 219: 354-64. PMID 19115233 DOI: 10.1002/Jcp.21677 |
0.401 |
|
| 2009 |
Das T, Bae YH, Wells A, Roy P. Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells. Journal of Cellular Physiology. 218: 436-43. PMID 18937284 DOI: 10.1002/Jcp.21618 |
0.401 |
|
| 2008 |
Yates CC, Whaley D, Y-Chen A, Kulesekaran P, Hebda PA, Wells A. ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. The American Journal of Pathology. 173: 643-52. PMID 18669615 DOI: 10.2353/Ajpath.2008.070990 |
0.785 |
|
| 2008 |
Shao H, Yi XM, Wells A. Epidermal growth factor protects fibroblasts from apoptosis via PI3 kinase and Rac signaling pathways. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 16: 551-8. PMID 18638274 DOI: 10.1111/J.1524-475X.2008.00402.X |
0.393 |
|
| 2008 |
Kim HD, Guo TW, Wu AP, Wells A, Gertler FB, Lauffenburger DA. Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence. Molecular Biology of the Cell. 19: 4249-59. PMID 18632979 DOI: 10.1091/Mbc.E08-05-0501 |
0.429 |
|
| 2008 |
Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clinical & Experimental Metastasis. 25: 621-8. PMID 18600305 DOI: 10.1007/S10585-008-9167-1 |
0.59 |
|
| 2008 |
Nozawa H, Howell G, Suzuki S, Zhang Q, Qi Y, Klein-Seetharaman J, Wells A, Grandis JR, Thomas SM. Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4336-44. PMID 18594017 DOI: 10.1158/1078-0432.Ccr-07-4857 |
0.392 |
|
| 2008 |
Tamama K, Sen CK, Wells A. Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells and Development. 17: 897-908. PMID 18564029 DOI: 10.1089/Scd.2007.0155 |
0.365 |
|
| 2008 |
Sharrow AC, Li Y, Micsenyi A, Griswold RD, Wells A, Monga SS, Blair HC. Modulation of osteoblast gap junction connectivity by serum, TNFalpha, and TRAIL. Experimental Cell Research. 314: 297-308. PMID 18022159 DOI: 10.1016/J.Yexcr.2007.10.010 |
0.326 |
|
| 2008 |
Iyer AK, Tran KT, Griffith L, Wells A. Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling. Journal of Cellular Physiology. 214: 504-12. PMID 17708541 DOI: 10.1002/Jcp.21232 |
0.757 |
|
| 2008 |
Kulasekaran P, Hebda PA, Satish L, Yager D, Hancock WW, Lu B, Wells A. 018
Role of the Receptor CXCR3 and its Ligand in Wound Healing Wound Repair and Regeneration. 13: A4-A27. DOI: 10.1111/J.1067-1927.2005.130215R.X |
0.402 |
|
| 2008 |
Bodnar RJ, Wells A. 057 Activation of CXCR 3 Inhibits Endothelial Tube Formation Through the Modulation of M-Calpain Wound Repair and Regeneration. 13. DOI: 10.1111/J.1067-1927.2005.130215Be.X |
0.385 |
|
| 2007 |
Zou L, Jaramillo M, Whaley D, Wells A, Panchapakesa V, Das T, Roy P. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. British Journal of Cancer. 97: 1361-1371. PMID 17940506 DOI: 10.1038/Sj.Bjc.6604038 |
0.381 |
|
| 2007 |
Joslin EJ, Opresko LK, Wells A, Wiley HS, Lauffenburger DA. EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation. Journal of Cell Science. 120: 3688-99. PMID 17895366 DOI: 10.1242/Jcs.010488 |
0.408 |
|
| 2007 |
Yaroslavskiy BB, Sharrow AC, Wells A, Robinson LJ, Blair HC. Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility. Journal of Cell Science. 120: 2884-94. PMID 17690304 DOI: 10.1242/Jcs.004184 |
0.341 |
|
| 2007 |
Yates CC, Whaley D, Kulasekeran P, Hancock WW, Lu B, Bodnar R, Newsome J, Hebda PA, Wells A. Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. The American Journal of Pathology. 171: 484-95. PMID 17600132 DOI: 10.2353/Ajpath.2007.061092 |
0.795 |
|
| 2007 |
Blair HC, Wells A, Isales CM. Pituitary glycoprotein hormone receptors in non-endocrine organs. Trends in Endocrinology and Metabolism: Tem. 18: 227-33. PMID 17588768 DOI: 10.1016/J.Tem.2007.06.001 |
0.305 |
|
| 2007 |
Yates CC, Whaley D, Babu R, Zhang J, Krishna P, Beckman E, Pasculle AW, Wells A. The effect of multifunctional polymer-based gels on wound healing in full thickness bacteria-contaminated mouse skin wound models. Biomaterials. 28: 3977-86. PMID 17561250 DOI: 10.1016/J.Biomaterials.2007.05.008 |
0.757 |
|
| 2007 |
Yates C, Shepard CR, Papworth G, Dash A, Beer Stolz D, Tannenbaum S, Griffith L, Wells A. Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Advances in Cancer Research. 97: 225-46. PMID 17419948 DOI: 10.1016/S0065-230X(06)97010-9 |
0.584 |
|
| 2007 |
Kharait S, Hautaniemi S, Wu S, Iwabu A, Lauffenburger DA, Wells A. Decision tree modeling predicts effects of inhibiting contractility signaling on cell motility. Bmc Systems Biology. 1: 9. PMID 17408516 DOI: 10.1186/1752-0509-1-9 |
0.801 |
|
| 2007 |
Yates CC, Shepard CR, Stolz DB, Wells A. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. British Journal of Cancer. 96: 1246-52. PMID 17406365 DOI: 10.1038/Sj.Bjc.6603700 |
0.612 |
|
| 2007 |
Iyer AK, Tran KT, Borysenko CW, Cascio M, Camacho CJ, Blair HC, Bahar I, Wells A. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. Journal of Cellular Physiology. 211: 748-58. PMID 17311283 DOI: 10.1002/Jcp.20986 |
0.731 |
|
| 2007 |
Fan VH, Tamama K, Au A, Littrell R, Richardson LB, Wright JW, Wells A, Griffith LG. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells (Dayton, Ohio). 25: 1241-51. PMID 17234993 DOI: 10.1634/Stemcells.2006-0320 |
0.4 |
|
| 2007 |
Shepard CR, Kassis J, Whaley DL, Kim HG, Wells A. PLC gamma contributes to metastasis of in situ-occurring mammary and prostate tumors. Oncogene. 26: 3020-6. PMID 17130835 DOI: 10.1038/Sj.Onc.1210115 |
0.347 |
|
| 2007 |
Shepard CR, Wells A. Demethylation of the E‐cadherin promoter driven by hepatocytes allows for cell fate‐determining signals in invasive breast cancer cells The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A77-C |
0.376 |
|
| 2006 |
Krishna P, Rosen CA, Branski RC, Wells A, Hebda PA. Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 135: 937-45. PMID 17141088 DOI: 10.1016/J.Otohns.2006.07.011 |
0.331 |
|
| 2006 |
Satish L, Lyons-Weiler J, Hebda PA, Wells A. Gene expression patterns in isolated keloid fibroblasts. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 14: 463-70. PMID 16939575 DOI: 10.1111/J.1743-6109.2006.00135.X |
0.325 |
|
| 2006 |
Smith BR, Wells A, Alexander CB, Bovill E, Campbell S, Dasgupta A, Fung M, Haller B, Howe JG, Parvin C, Peerschke E, Rinder H, Spitalnik S, Weiss R, Wener M, et al. Curriculum content and evaluation of resident competency in clinical pathology (laboratory medicine): a proposal. Human Pathology. 37: 934-68. PMID 16867855 DOI: 10.1016/J.Humpath.2006.01.034 |
0.602 |
|
| 2006 |
Zaman MH, Trapani LM, Sieminski AL, Siemeski A, Mackellar D, Gong H, Kamm RD, Wells A, Lauffenburger DA, Matsudaira P. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proceedings of the National Academy of Sciences of the United States of America. 103: 10889-94. PMID 16832052 DOI: 10.1073/Pnas.0604460103 |
0.4 |
|
| 2006 |
Smith BR, Wells A, Alexander CB, Bovill E, Campbell S, Dasgupta A, Fung M, Haller B, Howe JG, Parvin C, Peerschke E, Rinder H, Spitalnik S, Weiss R, Wener M, et al. Curriculum content and evaluation of resident competency in clinical pathology (laboratory medicine): a proposal. American Journal of Clinical Pathology. 125: S3-37. PMID 16830955 DOI: 10.1309/4U6X62R0Rxbwe9Kh |
0.603 |
|
| 2006 |
Shao H, Chou J, Baty CJ, Burke NA, Watkins SC, Stolz DB, Wells A. Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation. Molecular and Cellular Biology. 26: 5481-96. PMID 16809781 DOI: 10.1128/Mcb.02243-05 |
0.377 |
|
| 2006 |
Zhou W, Grandis JR, Wells A. STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines. British Journal of Cancer. 95: 164-71. PMID 16804520 DOI: 10.1038/Sj.Bjc.6603234 |
0.623 |
|
| 2006 |
Wells A, Harms B, Iwabu A, Koo L, Smith K, Griffith L, Lauffenburger DA. Motility signaled from the EGF receptor and related systems Methods in Molecular Biology (Clifton, N.J.). 327: 159-177. PMID 16780220 DOI: 10.1385/1-59745-012-X:159 |
0.414 |
|
| 2006 |
Babu R, Zhang J, Beckman EJ, Virji M, Pasculle WA, Wells A. Antimicrobial activities of silver used as a polymerization catalyst for a wound-healing matrix. Biomaterials. 27: 4304-14. PMID 16635526 DOI: 10.1016/J.Biomaterials.2006.03.038 |
0.358 |
|
| 2006 |
Smith KD, Wells A, Lauffenburger DA. Multiple signaling pathways mediate compaction of collagen matrices by EGF-stimulated fibroblasts Experimental Cell Research. 312: 1970-1982. PMID 16595133 DOI: 10.1016/J.Yexcr.2006.02.022 |
0.403 |
|
| 2006 |
Smith BR, Wells A, Alexander CB, Bovill E, Campbell S, Dasgupta A, Fung M, Haller B, Howe JG, Parvin C, Peerschke E, Rinder H, Spitalnik S, Weiss R, Wener M. Curriculum content and evaluation of resident competency in clinical pathology (laboratory medicine): a proposal. Clinical Chemistry. 52: 917-49. PMID 16569705 DOI: 10.1373/Clinchem.2005.066076 |
0.603 |
|
| 2006 |
Kharait S, Dhir R, Lauffenburger D, Wells A. Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells. Biochemical and Biophysical Research Communications. 343: 848-56. PMID 16564022 DOI: 10.1016/J.Bbrc.2006.03.044 |
0.806 |
|
| 2006 |
Bodnar RJ, Yates CC, Wells A. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circulation Research. 98: 617-25. PMID 16484616 DOI: 10.1161/01.Res.0000209968.66606.10 |
0.785 |
|
| 2006 |
Yu G, Tseng GC, Yu YP, Gavel T, Nelson J, Wells A, Michalopoulos G, Kokkinakis D, Luo JH. CSR1 suppresses tumor growth and metastasis of prostate cancer. The American Journal of Pathology. 168: 597-607. PMID 16436673 DOI: 10.2353/Ajpath.2006.050620 |
0.329 |
|
| 2006 |
Tamama K, Fan VH, Griffith LG, Blair HC, Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells (Dayton, Ohio). 24: 686-95. PMID 16150920 DOI: 10.1634/stemcells.2005-0176 |
0.342 |
|
| 2005 |
Wells A, Huttenlocher A, Lauffenburger DA. Calpain proteases in cell adhesion and motility International Review of Cytology. 245: 1-16. PMID 16125543 DOI: 10.1016/S0074-7696(05)45001-9 |
0.435 |
|
| 2005 |
Wang J, Zhang X, Thomas SM, Grandis JR, Wells A, Chen ZG, Ferris RL. Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene. 24: 5897-904. PMID 16007209 DOI: 10.1038/Sj.Onc.1208740 |
0.454 |
|
| 2005 |
Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene. 24: 4442-9. PMID 15856028 DOI: 10.1038/Sj.Onc.1208635 |
0.43 |
|
| 2005 |
Satish L, Blair HC, Glading A, Wells A. Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. Molecular and Cellular Biology. 25: 1922-41. PMID 15713646 DOI: 10.1128/Mcb.25.5.1922-1941.2005 |
0.762 |
|
| 2005 |
Hautaniemi S, Kharait S, Iwabu A, Wells A, Lauffenburger DA. Modeling of signal-response cascades using decision tree analysis Bioinformatics. 21: 2027-2035. PMID 15657095 DOI: 10.1093/Bioinformatics/Bti278 |
0.799 |
|
| 2005 |
Yates C, Wells A, Turner T. Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. British Journal of Cancer. 92: 366-75. PMID 15655536 DOI: 10.1038/Sj.Bjc.6602350 |
0.664 |
|
| 2005 |
Hendriks BS, Orr G, Wells A, Wiley HS, Lauffenburger DA. Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells. The Journal of Biological Chemistry. 280: 6157-69. PMID 15572377 DOI: 10.1074/Jbc.M410491200 |
0.41 |
|
| 2005 |
Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR. Erratum: Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma Oncogene. 24: 8216-8216. DOI: 10.1038/Sj.Onc.1209224 |
0.349 |
|
| 2004 |
Priya KS, Arumugam G, Rathinam B, Wells A, Babu M. Celosia argentea Linn. leaf extract improves wound healing in a rat burn wound model. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 12: 618-25. PMID 15555053 DOI: 10.1111/J.1067-1927.2004.12603.X |
0.35 |
|
| 2004 |
Wells A, Lillien L. Attraction or repulsion: a matter of individual taste? Science's Stke : Signal Transduction Knowledge Environment. 2004: pe47. PMID 15467095 DOI: 10.1126/Stke.2532004Pe47 |
0.453 |
|
| 2004 |
Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Experimental Cell Research. 299: 91-100. PMID 15302576 DOI: 10.1016/J.Yexcr.2004.05.008 |
0.82 |
|
| 2004 |
Tran KT, Griffith L, Wells A. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 12: 262-8. PMID 15225204 DOI: 10.1111/J.1067-1927.2004.012302.X |
0.683 |
|
| 2004 |
Jing L, Liu L, Yu YP, Dhir R, Acquafondada M, Landsittel D, Cieply K, Wells A, Luo JH. Expression of myopodin induces suppression of tumor growth and metastasis. The American Journal of Pathology. 164: 1799-806. PMID 15111326 DOI: 10.1016/S0002-9440(10)63738-8 |
0.352 |
|
| 2004 |
Satish L, Babu M, Tran KT, Hebda PA, Wells A. Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 12: 183-92. PMID 15086770 DOI: 10.1111/J.1067-1927.2004.012111.X |
0.72 |
|
| 2004 |
Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, Potter DA, Blair HC, Wells A. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Molecular and Cellular Biology. 24: 2499-512. PMID 14993287 DOI: 10.1128/Mcb.24.6.2499-2512.2004 |
0.733 |
|
| 2004 |
Iwabu A, Smith K, Allen FD, Lauffenburger DA, Wells A. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. The Journal of Biological Chemistry. 279: 14551-60. PMID 14747473 DOI: 10.1074/Jbc.M311981200 |
0.409 |
|
| 2004 |
Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, Potter DA, Blair HC, Wells A. Erratum: Epidermal growth factor activates m-Calpain (Calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation (Molecular and Cellular Biology (2004) 24, 6 (2499-2512)) Molecular and Cellular Biology. 24. DOI: 10.1128/Mcb.24.13.6116.2004 |
0.733 |
|
| 2004 |
Satish L, Luo J, Priya KS, Wells A. 139 Gene Array Profiling of Keloid Fibroblasts to Identify the Target Genes for Therapeutic Evaluations Wound Repair and Regeneration. 12. DOI: 10.1111/J.1067-1927.2004.0Abstracteh.X |
0.397 |
|
| 2004 |
Tamama K, Lincoln T, Wells A. The Restoration Of Protein Kinase G To Differentiate Bone Marrow Mesenchymal Stem Cell Into Vascular Smooth Muscle Cells Cardiovascular Pathology. 13: 173. DOI: 10.1016/J.Carpath.2004.03.518 |
0.311 |
|
| 2003 |
Tran KT, Rusu SD, Satish L, Wells A. Aging-related attenuation of EGF receptor signaling is mediated in part by increased protein tyrosine phosphatase activity. Experimental Cell Research. 289: 359-67. PMID 14499637 DOI: 10.1016/S0014-4827(03)00287-8 |
0.682 |
|
| 2003 |
Hebda PA, Whaley D, Kim H, Wells A. Absence of inhibition of cutaneous wound healing in mice by oral doxycycline. Wound Repair and Regeneration. 11: 373-379. PMID 12950642 DOI: 10.1046/J.1524-475X.2003.11510.X |
0.332 |
|
| 2003 |
Ochs RL, Fensterer J, Ohori NP, Wells A, Gabrin M, George LD, Kornblith P. Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors. In Vitro Cellular & Developmental Biology. Animal. 39: 63-70. PMID 12892529 DOI: 10.1290/1543-706X(2003)039<0063:Eftiga>2.0.Co;2 |
0.352 |
|
| 2003 |
Wells A, Grandis JR. Phospholipase C-gamma1 in tumor progression. Clinical & Experimental Metastasis. 20: 285-90. PMID 12856715 DOI: 10.1023/A:1024088922957 |
0.338 |
|
| 2003 |
Chou J, Burke NA, Iwabu A, Watkins SC, Wells A. Directional motility induced by epidermal growth factor requires Cdc42. Experimental Cell Research. 287: 47-56. PMID 12799181 DOI: 10.1016/S0014-4827(03)00119-8 |
0.448 |
|
| 2003 |
Satish L, Yager D, Wells A. Glu-Leu-Arg-negative CXC chemokine interferon gamma inducible protein-9 as a mediator of epidermal-dermal communication during wound repair. The Journal of Investigative Dermatology. 120: 1110-7. PMID 12787142 DOI: 10.1046/J.1523-1747.2003.12230.X |
0.399 |
|
| 2003 |
Lauffenburger DA, Wells A. Quantitative parsing of cell multi-tasking in wound repair and tissue morphogenesis. Biophysical Journal. 84: 3499-500. PMID 12770862 DOI: 10.1016/S0006-3495(03)75084-X |
0.401 |
|
| 2002 |
Wells A, Marti U. Signalling shortcuts: cell-surface receptors in the nucleus? Nature Reviews Molecular Cell Biology. 3: 697-702. PMID 12209129 DOI: 10.1038/Nrm905 |
0.39 |
|
| 2002 |
Kassis J, Maeda A, Teramoto N, Takada K, Wu C, Klein G, Wells A. EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness. International Journal of Cancer. 99: 644-51. PMID 12115496 DOI: 10.1002/Ijc.10382 |
0.517 |
|
| 2002 |
Wells A, Kassis J, Solava J, Turner T, Lauffenburger DA. Growth factor-induced cell motility in tumor invasion. Acta Oncologica (Stockholm, Sweden). 41: 124-30. PMID 12102155 DOI: 10.1080/028418602753669481 |
0.422 |
|
| 2002 |
Allen FD, Asnes CF, Chang P, Elson EL, Lauffenburger DA, Wells A. Epidermal growth factor induces acute matrix contraction and subsequent calpain-modulated relaxation. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 10: 67-76. PMID 11983008 DOI: 10.1046/J.1524-475X.2002.10701.X |
0.449 |
|
| 2002 |
Chou J, Stolz DB, Burke NA, Watkins SC, Wells A. Distribution of gelsolin and phosphoinositol 4,5-bisphosphate in lamellipodia during EGF-induced motility. The International Journal of Biochemistry & Cell Biology. 34: 776-790. PMID 11950594 DOI: 10.1016/S1357-2725(01)00177-7 |
0.363 |
|
| 2002 |
Kassis J, Radinsky R, Wells A. Motility is rate-limiting for invasion of bladder carcinoma cell lines. The International Journal of Biochemistry & Cell Biology. 34: 762-75. PMID 11950593 DOI: 10.1016/S1357-2725(01)00173-X |
0.404 |
|
| 2002 |
Shiraha H, Glading A, Chou J, Jia Z, Wells A. Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Molecular and Cellular Biology. 22: 2716-27. PMID 11909964 DOI: 10.1128/Mcb.22.8.2716-2727.2002 |
0.733 |
|
| 2002 |
Glading A, Lauffenburger DA, Wells A. Cutting to the chase: calpain proteases in cell motility. Trends in Cell Biology. 12: 46-54. PMID 11854009 DOI: 10.1016/S0962-8924(01)02179-1 |
0.756 |
|
| 2001 |
Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, Wells A. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. The Journal of Cell Biology. 154: 459-68. PMID 11470832 DOI: 10.1083/Jcb.200103103 |
0.67 |
|
| 2001 |
Manos EJ, Kim ML, Kassis J, Chang PY, Wells A, Jones DA. Dolichol-phosphate-mannose-3 (DPM3)/prostin-1 is a novel phospholipase C-gamma regulated gene negatively associated with prostate tumor invasion. Oncogene. 20: 2781-90. PMID 11420690 DOI: 10.1038/Sj.Onc.1204379 |
0.383 |
|
| 2001 |
Lauffenburger DA, Wells A. Getting a grip: new insights for cell adhesion and traction. Nature Cell Biology. 3. PMID 11331893 DOI: 10.1038/35074631 |
0.399 |
|
| 2001 |
Kassis J, Lauffenburger DA, Turner T, Wells A. Tumor invasion as dysregulated cell motility Seminars in Cancer Biology. 11: 105-117. PMID 11322830 DOI: 10.1006/Scbi.2000.0362 |
0.444 |
|
| 2001 |
Glading A, Überall F, Keyse SM, Lauffenburger DA, Wells A. Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. Journal of Biological Chemistry. 276: 23341-23348. PMID 11319218 DOI: 10.1074/Jbc.M008847200 |
0.769 |
|
| 2001 |
Deb TB, Su L, Wong L, Bonvini E, Wells A, David M, Johnson GR. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF. The Journal of Biological Chemistry. 276: 15554-60. PMID 11279155 DOI: 10.1074/Jbc.M100928200 |
0.408 |
|
| 2000 |
Botelho RJ, Teruel M, Dierckman R, Anderson R, Wells A, York JD, Meyer T, Grinstein S. Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. The Journal of Cell Biology. 151: 1353-68. PMID 11134066 DOI: 10.1083/Jcb.151.7.1353 |
0.311 |
|
| 2000 |
Barbieri MA, Roberts RL, Gumusboga A, Highfield H, Alvarez-Dominguez C, Wells A, Stahl PD. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. The Journal of Cell Biology. 151: 539-50. PMID 11062256 DOI: 10.1083/Jcb.151.3.539 |
0.401 |
|
| 2000 |
Haugh JM, Wells A, Lauffenburger DA. Mathematical modeling of epidermal growth factor receptor signaling through the phospholipase C pathway: mechanistic insights and predictions for molecular interventions. Biotechnology and Bioengineering. 70: 225-38. PMID 10972934 DOI: 10.1002/1097-0290(20001020)70:2<225::Aid-Bit12>3.0.Co;2-S |
0.383 |
|
| 2000 |
Shiraha H, Gupta K, Drabik K, Wells A. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. The Journal of Biological Chemistry. 275: 19343-51. PMID 10764734 DOI: 10.1074/Jbc.M000008200 |
0.454 |
|
| 2000 |
Marti U, Wells A. The nuclear accumulation of a variant epidermal growth factor receptor (EGFR) lacking the transmembrane domain requires coexpression of a full-length EGFR. Molecular Cell Biology Research Communications. 3: 8-14. PMID 10683311 DOI: 10.1006/Mcbr.2000.0177 |
0.332 |
|
| 2000 |
Glading A, Chang P, Lauffenburger DA, Wells A. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. The Journal of Biological Chemistry. 275: 2390-8. PMID 10644690 DOI: 10.1074/Jbc.275.4.2390 |
0.755 |
|
| 1999 |
Wells A, Ware MF, Allen FD, Lauffenburger DA. Shaping up for shipping out: PLC? signaling of morphology changes in EGF-stimulated fibroblast migration Cytoskeleton. 44: 227-233. PMID 10602252 DOI: 10.1002/(Sici)1097-0169(199912)44:4<227::Aid-Cm1>3.0.Co;2-B |
0.453 |
|
| 1999 |
Haugh JM, Huang AC, Wiley HS, Wells A, Lauffenburger DA. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. The Journal of Biological Chemistry. 274: 34350-60. PMID 10567412 DOI: 10.1074/Jbc.274.48.34350 |
0.372 |
|
| 1999 |
Wells A. Tumor Invasion: Role of growth factor-induced cell motility Advances in Cancer Research. 78: 31-101. PMID 10547668 DOI: 10.1016/S0065-230X(08)61023-4 |
0.456 |
|
| 1999 |
Shiraha H, Glading A, Gupta K, Wells A. IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. Journal of Cell Biology. 146: 243-254. PMID 10402474 DOI: 10.1083/Jcb.146.1.243 |
0.771 |
|
| 1999 |
Maheshwari G, Wells A, Griffith LG, Lauffenburger DA. Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration. Biophysical Journal. 76: 2814-23. PMID 10233097 DOI: 10.1016/S0006-3495(99)77435-7 |
0.429 |
|
| 1999 |
Haugh JM, Schooler K, Wells A, Wiley HS, Lauffenburger DA. Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-gamma1 signaling pathway. The Journal of Biological Chemistry. 274: 8958-65. PMID 10085141 DOI: 10.1074/Jbc.274.13.8958 |
0.416 |
|
| 1999 |
Wong L, Deb TB, Thompson SA, Wells A, Johnson GR. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling. The Journal of Biological Chemistry. 274: 8900-9. PMID 10085134 DOI: 10.1074/Jbc.274.13.8900 |
0.422 |
|
| 1999 |
Radinsky R, Inoue K, Slaton JW, Kim Y, Portera CA, Dinney CPN, Kassis J, Wells A. Overexpression Of A Motility-Deficient Epidermal Growth Factor Receptor (Egf-R) In Human Transitional Cell Carcinoma (Tcc) Inhibits Matrixmetalloprotease-9 (Mmp-9)-Mediated Motility, Angiogenesis, And Metastasis In Nude Mice The Journal of Urology. 111. DOI: 10.1097/00005392-199904010-00447 |
0.381 |
|
| 1998 |
Reddy CC, Wells A, Lauffenburger DA. Comparative mitogenic potencies of EGF and TGFα and their dependence on receptor-limitation versus ligand-limitation Medical & Biological Engineering & Computing. 36: 499-507. PMID 10198537 DOI: 10.1007/Bf02523222 |
0.362 |
|
| 1998 |
Wells A, Gupta K, Chang P, Swindle S, Glading A, Shiraha H. Epidermal growth factor receptor-mediated motility in fibroblasts. Microscopy Research and Technique. 43: 395-411. PMID 9858337 DOI: 10.1002/(Sici)1097-0029(19981201)43:5<395::Aid-Jemt6>3.0.Co;2-T |
0.771 |
|
| 1998 |
Turner T, Jackson WH, Pettit GR, Wells A, Kraft AS. Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc Prostate. 34: 175-181. PMID 9492845 DOI: 10.1002/(Sici)1097-0045(19980215)34:3<175::Aid-Pros4>3.0.Co;2-H |
0.345 |
|
| 1998 |
Wells A. Introduction to cell motility Microscopy Research and Technique. 43: 357. DOI: 10.1002/(Sici)1097-0029(19981201)43:5<357::Aid-Jemt1>3.0.Co;2-H |
0.371 |
|
| 1997 |
Epps-Fung MV, Gupta K, Hardy RW, Wells A. A role for phospholipase C activity in GLUT4-mediated glucose transport. Endocrinology. 138: 5170-5175. PMID 9389497 DOI: 10.1210/Endo.138.12.5596 |
0.334 |
|
| 1997 |
Hardy RW, Wickramasinghe NSMD, Ke SC, Wells A. Fatty acids and breast cancer cell proliferation Advances in Experimental Medicine and Biology. 422: 57-69. PMID 9361815 DOI: 10.1007/978-1-4757-2670-1_5 |
0.339 |
|
| 1997 |
Zhang M, Wang MH, Singh RK, Wells A, Siegal GP. Epidermal growth factor induces CD44 gene expression through a novel regulatory element in mouse fibroblasts. The Journal of Biological Chemistry. 272: 14139-46. PMID 9162042 DOI: 10.1074/Jbc.272.22.14139 |
0.422 |
|
| 1996 |
Lauffenburger DA, Chu L, French A, Oehrtman G, Reddy C, Wells A, Niyogi S, Wiley HS. Engineering dynamics of growth factors and other therapeutic ligands Biotechnology and Bioengineering. 52: 61-80. PMID 18629852 DOI: 10.1002/(Sici)1097-0290(19961005)52:1<61::Aid-Bit6>3.0.Co;2-X |
0.378 |
|
| 1996 |
Turner T, Chen P, Goodly LJ, Wells A. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells Clinical & Experimental Metastasis. 14: 409-418. PMID 8878415 DOI: 10.1007/Bf00123400 |
0.615 |
|
| 1996 |
Van Epps-Fung M, Hardy RW, Williford J, Gupta K, Wells A. Epidermal growth factor induces glucose storage in transgenic 3T3-L1 adipocytes overexpressing epidermal growth factor receptors Diabetes. 45: 1619-1625. PMID 8866569 DOI: 10.2337/Diab.45.11.1619 |
0.311 |
|
| 1996 |
Chen P, Xie H, Wells A. Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism. Molecular Biology of the Cell. 7: 871-881. PMID 8816994 DOI: 10.1091/Mbc.7.6.871 |
0.438 |
|
| 1996 |
Chen P, Murphy-Ullrich JE, Wells A. A role for gelsolin in actuating epidermal growth factor receptor- mediated cell motility Journal of Cell Biology. 134: 689-698. PMID 8707848 DOI: 10.1083/Jcb.134.3.689 |
0.623 |
|
| 1996 |
Zhang M, Singh RK, Wang MH, Wells A, Siegal GP. Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44. Clinical & Experimental Metastasis. 14: 268-76. PMID 8674281 DOI: 10.1007/Bf00053900 |
0.418 |
|
| 1996 |
David M, Wong L, Flavell R, Thompson SA, Wells A, Larner AC, Johnson GR. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. The Journal of Biological Chemistry. 271: 9185-8. PMID 8621573 DOI: 10.1074/Jbc.271.16.9185 |
0.397 |
|
| 1996 |
Reddy CC, Wells A, Lauffenburger DA. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor α Journal of Cellular Physiology. 166: 512-522. PMID 8600155 DOI: 10.1002/(Sici)1097-4652(199603)166:3<512::Aid-Jcp6>3.0.Co;2-S |
0.354 |
|
| 1995 |
Hardy RW, Gupta KB, McDonald JM, Williford J, Wells A. Epidermal growth factor (EGF) receptor carboxy-terminal domains are required for EGF-induced glucose transport in transgenic 3T3-L1 adipocytes Endocrinology. 136: 431-439. PMID 7835273 DOI: 10.1210/Endo.136.2.7835273 |
0.31 |
|
| 1995 |
Xie H, Turner T, Wang MH, Singh RK, Siegal GP, Wells A. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clinical & Experimental Metastasis. 13: 407-19. PMID 7586799 DOI: 10.1007/Bf00118180 |
0.726 |
|
| 1994 |
Chen P, Gupta K, Wells A. Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis Journal of Cell Biology. 124: 547-555. PMID 8106552 DOI: 10.1083/Jcb.124.4.547 |
0.603 |
|
| 1994 |
Chen P, Xie H, Sekar MC, Gupta K, Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. Journal of Cell Biology. 127: 847-857. PMID 7962064 DOI: 10.1083/Jcb.127.3.847 |
0.763 |
|
| 1994 |
Reddy CC, Wells A, Lauffenburger DA. Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect. Biotechnology Progress. 10: 377-384. PMID 7765094 DOI: 10.1021/Bp00028A006 |
0.439 |
|
| 1991 |
Welsh JB, Gill GN, Rosenfeld MG, Wells A. A negative feedback loop attenuates EGF-induced morphological changes. The Journal of Cell Biology. 114: 533-43. PMID 1860884 DOI: 10.1083/Jcb.114.3.533 |
0.393 |
|
| 1991 |
Marti U, Burwen SJ, Wells A, Barker ME, Huling S, Feren AM, Jones AL. Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology. 13: 15-20. DOI: 10.1002/Hep.1840130104 |
0.333 |
|
| 1990 |
Wells A, Welsh JB, Lazar CS, Wiley HS, Gill GN, Rosenfeld MG. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science (New York, N.Y.). 247: 962-4. PMID 2305263 DOI: 10.1126/Science.2305263 |
0.41 |
|
| 1989 |
Wells A. The epidermal growth factor receptor and its ligands Cancer Treatment and Research. 47: 143-168. PMID 2576995 DOI: 10.1007/978-1-4613-1599-5_6 |
0.411 |
|
| 1988 |
Wells A, Bishop JM, Helmeste D. Amplified gene for the epidermal growth factor receptor in a human glioblastoma cell line encodes an enzymatically inactive protein. Molecular and Cellular Biology. 8: 4561-5. PMID 3263568 DOI: 10.1128/mcb.8.10.4561-4565.1988 |
0.505 |
|
| 1988 |
Wells A, Bishop JM. Genetic determinants of neoplastic transformation by the retroviral oncogene v-erbB. Proceedings of the National Academy of Sciences of the United States of America. 85: 7597-601. PMID 2902633 DOI: 10.1073/Pnas.85.20.7597 |
0.498 |
|
| 1984 |
Wells A, Koide N, Eggertsen G, Lundwall A, Godal T, Steen HB, Klein G. Epstein-Barr virus binding to virus-carrying cell lines is enhanced in the presence of C3 and C3d. The Journal of General Virology. 507-13. PMID 6321638 DOI: 10.1099/0022-1317-65-3-507 |
0.418 |
|
| 1983 |
Jønsson V, Wells A, Klein G. Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids. Cellular Immunology. 72: 263-76. PMID 6983911 DOI: 10.1016/0008-8749(82)90474-9 |
0.318 |
|
| 1983 |
Wells A, Koide N, Stein H, Gerdes J, Klein G. The Epstein-Barr virus receptor is distinct from the C3 receptor. The Journal of General Virology. 449-53. PMID 6300295 DOI: 10.1099/0022-1317-64-2-449 |
0.425 |
|
| 1982 |
Wells A, Godal T, Kvaløy S, Steen HB, Klein G. Quantitative comparison of Epstein-Barr virus receptor expression on sIgM and sIgG cell lines and B-cell lymphoma biopsies. Differentiation; Research in Biological Diversity. 22: 113-9. PMID 6290303 DOI: 10.1111/J.1432-0436.1982.Tb01234.X |
0.471 |
|
| 1982 |
Koide N, Wells A, Klein G, Ernberg I. Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines. Intervirology. 16: 142-8. PMID 6277822 DOI: 10.1159/000149261 |
0.401 |
|
| 1982 |
Wells A, Steen H, Saeland S, Godal T, Klein G. A microassay for quantitatively detecting the Epstein-Barr virus receptor on single cells utilizing flow cytometry. Journal of Virological Methods. 3: 127-36. PMID 6271799 DOI: 10.1016/0166-0934(81)90047-1 |
0.419 |
|
| 1981 |
Koide N, Wells A, Volsky DJ, Shapiro IM, Klein G. The detection of Epstein-Barr virus receptors utilizing radiolabelled virus. The Journal of General Virology. 54: 191-5. PMID 6270245 DOI: 10.1099/0022-1317-54-1-191 |
0.415 |
|
| 1981 |
Wells A, Koide N, Klein G. Difference in viral binding between two Epstein-Barr virus substrains to a spectrum of receptor-positive target cells. International Journal of Cancer. 27: 303-9. PMID 6270014 DOI: 10.1002/Ijc.2910270308 |
0.415 |
|
| Show low-probability matches. |